DE60212464D1 - Herstellung von tabletten von pharmazeutisch aktiven substanzen mit ungünstigen tablettierungseigenschaften mit einer mikrokristalline zellulose enthaltenden granulierflüssigkeit - Google Patents

Herstellung von tabletten von pharmazeutisch aktiven substanzen mit ungünstigen tablettierungseigenschaften mit einer mikrokristalline zellulose enthaltenden granulierflüssigkeit

Info

Publication number
DE60212464D1
DE60212464D1 DE60212464T DE60212464T DE60212464D1 DE 60212464 D1 DE60212464 D1 DE 60212464D1 DE 60212464 T DE60212464 T DE 60212464T DE 60212464 T DE60212464 T DE 60212464T DE 60212464 D1 DE60212464 D1 DE 60212464D1
Authority
DE
Germany
Prior art keywords
microcrystalline cellulose
tablets
preparation
pharmaceutically active
invalid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60212464T
Other languages
English (en)
Other versions
DE60212464T2 (de
Inventor
Pal Fekete
Ignacz Maria Kiralyne
Szell Zsuzsa Szlavyne
Laszlone Gora
Zoltanne Palfi
Istvanne Jambor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29287270&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60212464(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Egyt Gyogyszervegyeszeti Gyar, Egis Pharmaceuticals PLC filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of DE60212464D1 publication Critical patent/DE60212464D1/de
Application granted granted Critical
Publication of DE60212464T2 publication Critical patent/DE60212464T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
DE60212464T 2002-04-29 2002-04-29 Herstellung von tabletten von pharmazeutisch aktiven substanzen mit ungünstigen tablettierungseigenschaften mit einer mikrokristalline zellulose enthaltenden granulierflüssigkeit Expired - Fee Related DE60212464T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/HU2002/000035 WO2003092658A1 (en) 2002-04-29 2002-04-29 A process for the preparation of tablets from pharmaceutically active substances having unfavourable tabletting properties with a granulating liquid comprising microcrystalline cellulose

Publications (2)

Publication Number Publication Date
DE60212464D1 true DE60212464D1 (de) 2006-07-27
DE60212464T2 DE60212464T2 (de) 2007-01-11

Family

ID=29287270

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60212464T Expired - Fee Related DE60212464T2 (de) 2002-04-29 2002-04-29 Herstellung von tabletten von pharmazeutisch aktiven substanzen mit ungünstigen tablettierungseigenschaften mit einer mikrokristalline zellulose enthaltenden granulierflüssigkeit

Country Status (14)

Country Link
US (1) US20050163836A1 (de)
EP (1) EP1501484B2 (de)
AT (1) ATE329582T1 (de)
AU (1) AU2002258002A1 (de)
CZ (1) CZ296100B6 (de)
DE (1) DE60212464T2 (de)
DK (1) DK1501484T3 (de)
EA (1) EA006008B1 (de)
ES (1) ES2266496T3 (de)
HK (1) HK1073263A1 (de)
PT (1) PT1501484E (de)
SK (1) SK50232004A3 (de)
UA (1) UA75831C2 (de)
WO (1) WO2003092658A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9720061D0 (en) 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
US20050163846A1 (en) * 2001-11-21 2005-07-28 Eisai Co., Ltd. Preparation composition containing acid-unstable physiologically active compound, and process for producing same
HUP0301537A3 (en) * 2003-06-03 2005-07-28 Egis Gyogyszergyar Nyilvanosan Deramcyclane fumarate tablets and process for producing them
US7485319B2 (en) * 2003-07-25 2009-02-03 Warner Chilcott Company, Inc. Doxycycline metal complex in a solid dosage form
JPWO2005092336A1 (ja) * 2004-03-26 2008-02-07 エーザイ・アール・アンド・ディー・マネジメント株式会社 溶出制御製剤とその製造方法
US20090148519A1 (en) * 2005-09-29 2009-06-11 Yasuhiro Zaima Pulsed-release preparation having improved disintegration properties in vivo
MY157620A (en) 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
US20100105738A1 (en) * 2006-10-06 2010-04-29 Mitsuru Mizuno Extended release formulations of a proton pump inhibitor
GB0714670D0 (en) 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition
WO2012116434A1 (en) * 2011-03-01 2012-09-07 4413261 Canada Inc. (Spencer Canada) Two speed monolithic system for controlled release of drugs
EP3157516A4 (de) 2014-06-22 2017-12-13 Dexcel Pharma Technologies Ltd. Pharmazeutische zusammensetzungen mit eisencitrat und verfahren zur herstellung davon
RU2657424C1 (ru) * 2017-02-27 2018-06-13 Павел Владимирович Алексенко Способ производства таблеток

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3146168A (en) † 1962-04-10 1964-08-25 Fmc Corp Manufacture of pharmaceutical preparations containing cellulose crystallite aggregates
US4543332A (en) * 1982-03-29 1985-09-24 Miles Laboratories, Inc. Method for the preparation of spherical microorganism cell aggregates
US5073380A (en) * 1987-07-27 1991-12-17 Mcneil-Ppc, Inc. Oral sustained release pharmaceutical formulation and process
US4911921A (en) † 1989-02-02 1990-03-27 Mallinckrodt, Inc. High ibuprofen content granulations
JP2554305B2 (ja) † 1991-01-16 1996-11-13 エフ エム シー コーポレーション 水の存在下での崩壊性に優れた固形農薬
HU214588B (hu) † 1994-07-01 1998-04-28 EGIS Gyógyszergyár Rt. Eljárás bicikloheptán-származékot tartalmazó, CCK-rendszer gátló hatású gyógyászati készítmények előállítására
JPH10139659A (ja) * 1996-09-10 1998-05-26 Freunt Ind Co Ltd 球形粒子群、その製造方法及びそれを用いた球形粒子製剤
HU226061B1 (en) * 1996-10-17 2008-04-28 Egis Gyogyszergyar Nyilvanosan 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivative, pharmaceutical compositions containing the same and process for their preparation
WO1998036737A1 (en) * 1997-02-25 1998-08-27 The Procter & Gamble Company Wet granulating method
US6852337B2 (en) * 1998-04-09 2005-02-08 Roche Diagnostics Gmbh Carvedilol-galenics

Also Published As

Publication number Publication date
WO2003092658A1 (en) 2003-11-13
AU2002258002A1 (en) 2003-11-17
EP1501484A1 (de) 2005-02-02
CZ20041145A3 (cs) 2005-03-16
EA006008B1 (ru) 2005-08-25
HK1073263A1 (en) 2005-09-30
EP1501484B2 (de) 2010-07-07
CZ296100B6 (cs) 2006-01-11
SK50232004A3 (sk) 2005-04-01
EP1501484B1 (de) 2006-06-14
UA75831C2 (en) 2006-05-15
PT1501484E (pt) 2006-10-31
DK1501484T3 (da) 2006-10-23
ES2266496T3 (es) 2007-03-01
ATE329582T1 (de) 2006-07-15
EA200401418A1 (ru) 2005-04-28
US20050163836A1 (en) 2005-07-28
DE60212464T2 (de) 2007-01-11

Similar Documents

Publication Publication Date Title
HK1073263A1 (en) A process for the preparation of tablets from pharmaceutically active substances having unfavourabletabletting properties with a granulating liquid c omprising microcrystalline cellulose
Gharti et al. Formulation in vitro evaluation of floating tablets of hydroxypropyl methylcellulose and polyethylene oxide using ranitidine hydrochloride as a model drug
MX9701465A (es) Formulacion de acetaminofeno, de liberacion sostenida.
DE69838300D1 (de) Pharmazeutische suspensionstabletten-zusammenstellungen
ATE261300T1 (de) Direktverpressbare, ultrafeine acetaminophenzusammensetzungen und verfahren zu ihrer herstellung
CA2084680A1 (en) Process for the manufacture of porous cellulose matrices
EP1843754B1 (de) Neue pharmazeutische zusammensetzung mit candesartan-cilexetil als lipophile kristalline substanz
ATE386506T1 (de) Verabreichung unlöslicher arzneistoffe
WO2001078725A3 (en) Modified release formulations containing a hypnotic agent
KR900012606A (ko) 이중 정제
HRP20060136A2 (en) Pellets containing venflaxine hydrochloride
BR0009759A (pt) Formulação agroquìmica na forma sólida granular, e, métodos para preparação de uma mistura de pulverização e para tratamento de plantas
CA2018167A1 (en) Sustained release pharmaceutical tablet
CA2330480A1 (en) Controlled release formulation of divalproex sodium
AU2793989A (en) Method for preparing a solid sustained release form of a functionally active composition and the dosage form so obtained
US20130149380A1 (en) Use of diatomaceous earth in the pharmaceutical industry
RU2006104009A (ru) Фармацевтическая препаративная форма
JPH0759502B2 (ja) 調節放出型剤形用の乾式直接圧縮組成物
RS51578B (en) SOLID PHARMACEUTICAL COMPOSITION CONTAINING TELITROMYCIN
RU98123101A (ru) Фармацевтическая композиция и фармацевтический препарат, содержащие калиевую, натриевую и трис соли оксапрозина, их применение для устранения или уменьшения боли у млекопитающего и для лечения воспаления и нарушений, связанных с воспалением у млекопитающего, способ получения фармацевтического препарата
MXPA05010254A (es) Composicion farmaceutica que contiene complejo de platino como sustancia activa y metodo de fabricacion de la misma.
Mulye et al. Use of dicalcium phosphate dihydrate for sustained release of highly water soluble drugs
BG108956A (en) A process for the preparation of tablets from pharmaceutically active substances having unfavourable tabletting properties with a granulating liquid comprising macrocrystalline cellulose
RU94026856A (ru) Ноотропное и транквилизирующее средство
ATE526961T1 (de) Pharmazeutische zusammensetzung mit atorvastatin als wirkstoff

Legal Events

Date Code Title Description
8363 Opposition against the patent
8339 Ceased/non-payment of the annual fee